Virtus ETF Advisers LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$81,281
-19.7%
40,040
-9.0%
0.05%
-18.3%
Q2 2023$101,255
-10.2%
44,024
+18.4%
0.06%
-3.2%
Q1 2023$112,707
-6.1%
37,197
-27.8%
0.06%
-1.6%
Q4 2022$119,986
+46.3%
51,496
+19.8%
0.06%
+90.9%
Q3 2022$82,000
-29.3%
42,988
+0.7%
0.03%
-23.3%
Q2 2022$116,000
+3.6%
42,675
+14.0%
0.04%
-14.0%
Q1 2022$112,000
-27.3%
37,448
-5.6%
0.05%
-13.8%
Q4 2021$154,000
-31.6%
39,675
-27.2%
0.06%
-81.3%
Q1 2016$225,00054,4710.31%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders